Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonists.
about
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsThe use of G-protein coupled receptor models in lead optimization.From laptop to benchtop to bedside: structure-based drug design on protein targets.The histamine H3 receptor: from discovery to clinical trials with pitolisantHomology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.A high-content screening platform with fluorescent chemical probes for the discovery of first-in-class therapeutics.The Histamine H3 Receptor: Structure, Pharmacology, and Function.Structure-based discovery and binding site analysis of histamine receptor ligands.Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verificationGPCR Homology Model Generation for Lead Optimization.Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies.
P2860
Q26827568-FFC658A7-985B-466E-B136-F03E13E9B5F8Q33893103-E76F592A-F409-4DB6-AA00-7B0255A5B8BCQ34153589-220B88A2-01B6-44E1-8EBE-51CDE65786A0Q34629532-0B183B0C-E2D8-491B-B844-8C0E4B27E7B2Q35181896-B303DAE2-EF2A-46C6-AFD3-FE6F1D6A7739Q36013948-2119D2A3-863B-48A0-B776-98C8B780484AQ38937634-959E29CE-D72A-42BD-A8AC-91B0D75538E8Q38972667-04AAF5FC-94D7-4842-B548-01FB6DCDDF23Q42370925-757ECE9F-0FC1-4124-A3A3-2144F175A1E9Q49501384-C608AB7A-CEB5-4833-8D66-EE303CADA2E0Q51699441-4A6D4B01-D84C-497B-B30C-2569ED5152CA
P2860
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonists.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Refined docking as a valuable ...... amine H3 receptor antagonists.
@ast
Refined docking as a valuable ...... amine H3 receptor antagonists.
@en
type
label
Refined docking as a valuable ...... amine H3 receptor antagonists.
@ast
Refined docking as a valuable ...... amine H3 receptor antagonists.
@en
prefLabel
Refined docking as a valuable ...... amine H3 receptor antagonists.
@ast
Refined docking as a valuable ...... amine H3 receptor antagonists.
@en
P2093
P356
P1476
Refined docking as a valuable ...... tamine H3 receptor antagonists
@en
P2093
C Robin Ganellin
Denis Danvy
Holger Stark
Isabelle Berrebi-Bertrand
Marc Capet
Olivia Poupardin-Olivier
Olivier Labeeuw
Philippe Robert
Thierry Calmels
Walter Schunack
P2860
P304
P356
10.1002/ARDP.200800042
P577
2008-10-01T00:00:00Z